Real-time SEC alerts Start Free →
Profitelligence
TEVA
TEVA LOW Impact

TEVA

Teva Pharmaceutical Reports 2025 Q1 Financial Results

| 8-K

Summary

On May 7, 2025, Teva Pharmaceutical Industries Ltd. announced its financial results for the first quarter of 2025. The announcement included details on the company's operations and financial condition for the period ending March 31, 2025. While specific financial figures are not detailed in the 8-K filing due to the absence of an attached press release, the filing references the information being furnished as Exhibit 99.1, which was not attached to this filing. Investors are directed to look for the press release for comprehensive financial details.

Profitelligence Profitelligence Alerts

Get alerts for TEVA

Be first to know when TEVA files with the SEC.

Set Up Alerts →

Filing Categories

General Statement No viable tag

Exhibits (1)

Advertisement

Official SEC Documents

TEVA
TEVA Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement